Yuichiro Akao

Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of <i>Cryptosporidium</i> Infection

Frederick S. Buckner, Ranae M. Ranade, J. Robert Gillespie et al. · Antimicrobial Agents and Chemotherapy · 2019 · 52 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Collaborative virtual screening to elaborate an imidazo[1,2- <i>a</i> ]pyridine hit series for visceral leishmaniasis

Yuichiro Akao, Stacie Canan, Yafeng Cao et al. · RSC Medicinal Chemistry · 2021 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery and Structure–Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious Antimalarials

Benoı̂t Laleu, Yuichiro Akao, Atsuko Ochida et al. · Journal of Medicinal Chemistry · 2021 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as <i>Plasmodium</i> Cytoplasmic Prolyl-tRNA Synthetase Inhibitors

Masanori Okaniwa, Akira Shibata, Atsuko Ochida et al. · ACS Infectious Diseases · 2021 · 25 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

High-throughput screening of small-molecules libraries identified antibacterials against clinically relevant multidrug-resistant A. baumannii and K. pneumoniae

Benjamin Blasco, Soojin Jang, Hiroki Terauchi et al. · EBioMedicine · 2024 · 22 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17